AzTrials
AzTrials

TraumatologyNCT07012850

Advanced Magnetic Resonance Imaging for Perioperative Evaluation of Dental, Oral and Maxillofacial Trauma

An observational study of Traumatology and Maxillofacial Trauma, run by Harald Essig at 1 site in Switzerland.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Dental, oral, and maxillofacial trauma represents a significant public health concern, with most cases resulting from accidents and occurring frequently in young adults. Diagnosis relies on clinical examination and imaging modalities like computed tomography (CT) and cone-beam computed tomography (CBCT), which are… Read more about this study

Who is it for?
Any age
What is being tested?
Magnetic Resonance Imaging
How many people
60 participants
Where
1 siteSwitzerland
Study dates
5 May 2025to 31 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Study Population from the University Hospital Zurich, Switzerland

Who may be able to join

  • Patients presenting with acute dental, oral and maxillofacial trauma
  • Age: 18 years and older
  • Able to give informed consent (documented by signature)
  • No prior radiation-based imaging for the current trauma episode

Who cannot join

  • Pregnant or lactating individuals
  • Known contraindications to MRI (e.g., pacemakers, certain implants)
  • Clinically significant concomitant diseases affecting imaging quality (e.g., severe neurocognitive disorders)
  • Inability to comply with MRI procedures or study protocol (e.g., due to language barriers, psychological disorders, or dementia)
  • Participation in other clinical trials that may interfere with the imaging study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Switzerland1 site
  • Department of Cranio-Maxillofacial and Oral Surgery, University Hospital Zurich

    Zurich, Canton of Zurich, 8091

Other trials in Switzerland

About this study

Dental, oral, and maxillofacial trauma represents a significant public health concern, with most cases resulting from accidents and occurring frequently in young adults. Diagnosis relies on clinical examination and imaging modalities like computed tomography (CT) and cone-beam computed tomography (CBCT), which are standard for hard tissue assessment but expose patients to ionizing radiation. To reduce radiation exposure while simultaneously allowing for the visualization of soft tissues, newer imaging methods, including magnetic resonance imaging (MRI), as well as Black Bone and CT-like MRI protocols (ZTE, UTE), are being explored. These MRI techniques offer high-resolution, non-ionizing alternatives, showing promise for diagnosing soft tissue injuries and fractures without radiation risks, especially beneficial for younger patients. This study aims to assess MRI's diagnostic capabilities for maxillofacial trauma, focusing on early diagnosis, artifact reduction, and comparison to conventional X-ray-based imaging, within a minimal-risk study framework.

This study aims to evaluate the diagnostic efficacy of MRI compared to X-ray-based imaging modalities (CT/CBCT) for detecting dental, oral, and maxillofacial fractures, with a specific focus on Black Bone and CT-like MRI techniques. Additionally, it investigates MRI's potential to reduce artifacts around osteosynthesis plates, enhancing postoperative imaging quality in the presence of metal hardware.

Being tested
Magnetic Resonance Imaging
Medical subject headings
Maxillofacial Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic Resonance ImagingDiagnostic test

    To reduce radiation exposure while simultaneously allowing for the visualization of soft tissues, newer imaging methods, including magnetic resonance imaging (MRI), as well as Black Bone and CT-like MRI protocols (ZTE, UTE), are being explored. These MRI techniques offer high-resolution, non-ionizing alternatives, showing promise for diagnosing soft tissue injuries and fractures without radiation risks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. qualitative imaging parameters

    Primary Outcome Measures:

    1. Qualitative Assessment of Imaging Quality

    Description: Image quality will be evaluated using a standardized 5-point Likert scale for the following parameters: overall image quality, artifact severity, fracture visibility, and bone-to-soft-tissue contrast. Each parameter will be scored independently.

    Unit of Measure: Score on a 5-point Likert scale (1 = poor, 5 = excellent)

    Measured: From enrollment to the end of treatment at week 5

  2. Quantitative Assessment of Fracture Dimensions

    Fracture length, width, and depth will be measured in millimeters across axial, sagittal, and coronal planes using standardized digital radiologic tools. Measurements will be taken by two blinded radiologists and averaged.

    Unit of Measure: Millimeters (mm).

    Measured: From enrollment to the end of treatment at week 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2025
  2. Study start5 May 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07012850
Sponsor's protocol ID
2024-02307
Status last verified
May 2025
First submitted
9 May 2025
Last updated
10 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Al-Haj Husain A, Sandhu S, Burian E, Precht MM, Sommer S, Frauenfelder T, Wagner MEH, Essig H. Intraoperative C-arm CBCT versus early postoperative MRI for the assessment of fracture reduction and osteosynthesis material positioning in cranio-maxillofacial trauma surgery. Oral Maxillofac Surg. 2026 Jun 26;30(1):101. doi: 10.1007/s10006-026-01588-8.

    PubMed 42360559
  • Al-Haj Husain A, Kessler P, Lie SAN, Sandhu S, Wagner MEH, Burian E, Zedler D, Precht MM, Sommer S, Frauenfelder T, Essig H. Comparative evaluation of MRI-based bone-targeted sequences and computed tomography for preoperative assessment of midfacial trauma. Sci Rep. 2026 Feb 18;16(1):9700. doi: 10.1038/s41598-026-40252-9.

    PubMed 41708704
  • Al-Haj Husain A, Sandhu S, Wagner MEH, Burian E, Lie SAN, Precht MM, Zedler D, Frauenfelder T, Hotker AM, Stadlinger B, Sommer S, Kessler P, Essig H. Diagnostic performance of CT and MRI in mandibular trauma assessment - a prospective comparative study. Oral Maxillofac Surg. 2025 Dec 27;30(1):12. doi: 10.1007/s10006-025-01496-3.

    PubMed 41454981

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatology and Maxillofacial Trauma, run by Harald Essig at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 10 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

qualitative imaging parameters (time frame: From enrollment to the end of treatment at week 5). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07012850, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in